← Back to Search

CARE App for Caregivers of Stem Cell Transplant Patients

N/A

Recruiting

Led By Areej El-Jawahri, MD

Research Sponsored by Massachusetts General Hospital

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 100 days post-hct

Awards & highlights

Study Summary

This trial studies if an app helps caregivers of stem cell transplant patients improve their quality of life.

Who is the study for?

This trial is for adult caregivers of cancer patients undergoing stem cell transplants. Participants must understand and speak English, as the CARE app is English-only. They should be closely involved with the patient, either living together or designated as a caregiver during transplant.Check my eligibility

What is being tested?

The study tests if a mobile application called CARE can help improve life quality for caregivers by providing psychosocial support. Caregivers will use this app alongside usual care methods to see if there's any benefit over standard practices alone.See study design

What are the potential side effects?

Since this intervention involves using an application for emotional and psychological support, no direct medical side effects are expected. However, users may experience stress or emotional discomfort when engaging with the content.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 100 days post hct

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 100 days post hct

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 100 days post hct for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Secondary outcome measures

Anxiety symptoms as measured by the Hospital Anxiety and Depression scale (HADS-Anxiety)

Caregiver quality of life (QOL) as measured by the Caregiver Oncology Quality of Life (CARGOQOL) questionnaire

Caregiving burden as measured by the Caregiver Reaction Assessment (CRA)

+2 more

Other outcome measures

Coping as measured by the Measure of Current Status (MOCS)

Self-efficacy as measured by the Cancer self-efficacy-transplant (CASE-t) scale

Usability of the CARE app using the System Usability Scale

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: CARE AppExperimental Treatment1 Intervention

Participants randomized to the CARE app + usual care will complete the following: Questionnaires at baseline, Day 10, Day 60, and Day 100 post-HCT use the CARE app from enrollment up to 60 days post-HCT: the CARE app includes 5 contains 5 modules and a 6th optional module receive usual care as per HCT practice which entails meeting with a transplant social worker prior to HCT and as needed for extra visits

Group II: Usual CareActive Control1 Intervention

Participants randomized to usual care will complete the following: Questionnaires at baseline, Day 10, Day 60, and Day 100. receive usual care as per HCT practice, which entails meeting with a transplant social worker prior to HCT and as needed for extra visits.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Massachusetts General HospitalLead Sponsor

2,935 Previous Clinical Trials

13,198,521 Total Patients Enrolled

1 Trials studying Blood Cancers

90 Patients Enrolled for Blood Cancers

The Leukemia and Lymphoma SocietyOTHER

82 Previous Clinical Trials

17,011 Total Patients Enrolled

Areej El-Jawahri, MDPrincipal InvestigatorMassachusetts General Hospital

18 Previous Clinical Trials

4,392 Total Patients Enrolled

Media Library

CARE Application Clinical Trial Eligibility Overview. Trial Name: NCT05709912 — N/A

Blood Cancers Research Study Groups: CARE App, Usual Care

Blood Cancers Clinical Trial 2023: CARE Application Highlights & Side Effects. Trial Name: NCT05709912 — N/A

CARE Application 2023 Treatment Timeline for Medical Study. Trial Name: NCT05709912 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are investigators accepting new participants for this trial at present?

"As per the clinicaltrials.gov listing, this study is no longer enrolling participants; its posting from July 1st 2023 and last update in February of that year confirm this fact. Nevertheless, there are 2500 other medical trials actively looking for patients at present."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Mobile CARE-App to Promote Coping for Caregivers of Patients Receiving Stem Cell Transplant

El-Jawahri, Areej,M.D. 2023. "Mobile CARE-App to Promote Coping for Caregivers of Patients Receiving Stem Cell Transplant". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05709912.